The Cancer Immunotherapy Market is undergoing a significant transformation, driven by rapid advancements in biotechnology, increasing cancer prevalence, and growing adoption of immune-based therapies. The Cancer Immunotherapy Market size is projected to reach US$ 319,946 million by 2031, expanding at a CAGR of 12.4% during 2025–2031. This strong growth reflects the increasing demand for...